Dor Neuropática Periférica Induzida pela Quimioterapia e o Impacto na Qualidade de Vida

Marta Oliveira; Paulo Reis-Pina

doi:10.20344/amp.19883

Chemotherapy-Induced Peripheral Neuropathic Pain and the Impact on the Quality of Life

Authors

Marta Oliveira Unidade de Saúde Familiar Cardilium. Agrupamento Centros de Saúde do Médio Tejo. Administração Regional de Saúde de Lisboa e Vale do Tejo. Torres Novas.
Paulo Reis-Pina Casa de Saúde da Idanha. Sintra; Faculdade de Medicina da Universidade de Lisboa. Lisboa. https://orcid.org/0000-0002-4665-585X

DOI:

https://doi.org/10.20344/amp.19883

Keywords:

Cancer Pain, Neuralgia, Peripheral Nervous System Diseases/chemically induced, Quality of Life

Abstract

N/a.

Downloads

Download data is not yet available.

References

Capela A, Alonso R, Araújo A, Craveiro-Lopes B, Fragoso RM, Mansinho H, et al. A dor neuropática periférica induzida por quimioterapia no doente oncológico/sobrevivente de cancro. Acta Med Port. 2023;36:77-80.

Colvin LA. Chemotherapy-induced peripheral neuropathy (CIPN): where are we now? Pain. 2019;160:S1–10.

Pachman DR, Barton DL, Swetz KM, Loprinzi CL. Troublesome symptoms in cancer survivors: fatigue, insomnia, neuropathy, and pain. J Clin Oncol. 2012;30:3687-96.

Seretny M, Currie GL, Sena ES, Ramnarine S, Grant R, MacLeod MR, et al. Incidence, prevalence and predictors of chemotherapy induced peripheral neuropathy: a systematic review and meta-analysis. Pain. 2014;155:2461-70.

Tanay M, Armes J, Ream E. The experience of chemotherapy-induced peripheral neuropathy in adult cancer patients: a qualitative thematic synthesis. Eur J Cancer Care. 2017;26:e12443.

Downloads

PDF (Português)

Published

2023-06-01

How to Cite

Oliveira M, Reis-Pina P. Chemotherapy-Induced Peripheral Neuropathic Pain and the Impact on the Quality of Life. Acta Med Port [Internet]. 2023 Jun. 1 [cited 2024 Nov. 14];36(6):440-. Available from: https://actamedicaportuguesa.com/revista/index.php/amp/article/view/19883

Download Citation

Issue

Vol. 36 No. 6 (2023): June

Section

Letters to the Editor

License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.

It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.

Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.

After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.